Clinical Use of Pegvisomant for the Treatment of Acromegaly

By Drake William M.  

Treatments in Endocrinology, Vol. 2, Iss. 6, 2003-01 ,pp. : 369-374

Adis International

Access to resources Recommend Favorite

Growth hormone receptor polymorphism and the effects of pegvisomant in acromegaly

By Bianchi Antonio   Mazziotti Gherardo   Tilaro Laura   Cimino Vincenzo   Veltri Flora   Gaetani Eleonora   Pecorini Giovanni   Pontecorvi Alfredo   Giustina Andrea   Marinis Laura  

Pituitary, Vol. 12, Iss. 3, 2009-09 ,pp. : 196-199

Springer Publishing Company

Access to resources Recommend Favorite

Growth hormone measurements in the diagnosis and monitoring of acromegaly

By Sata Akira   Ho Ken  

Pituitary, Vol. 10, Iss. 2, 2007-06 ,pp. : 165-172

Springer Publishing Company

Access to resources Recommend Favorite

Absence of immunostaining for growth hormone in a subset of patients with acromegaly

By Schroeder Jason   Spiotta Alejandro   Fleseriu Maria   Prayson Richard   Hamrahian Amir   Weil Robert  

Pituitary, Vol. 17, Iss. 2, 2014-04 ,pp. : 103-108

Springer Publishing Company

Access to resources Recommend Favorite

Growth hormone granulation pattern and somatostatin receptor subtype 2A correlate with postoperative somatostatin receptor ligand response in acromegaly: a large single center experience

By Brzana Jessica   Yedinak Chris   Gultekin Sakir   Delashaw Johnny   Fleseriu Maria  

Pituitary, Vol. 16, Iss. 4, 2013-12 ,pp. : 490-498

Springer Publishing Company

Access to resources Recommend Favorite